Moody Aldrich Partners’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-2,256
| Closed | -$1.96M | – | 180 |
|
2021
Q1 | $1.96M | Buy |
2,256
+33
| +1% | +$28.6K | 0.28% | 94 |
|
2020
Q4 | $2.06M | Buy |
2,223
+2
| +0.1% | +$1.85K | 0.33% | 91 |
|
2020
Q3 | $2.28M | Buy |
2,221
+61
| +3% | +$62.7K | 0.48% | 86 |
|
2020
Q2 | $2.19M | Buy |
2,160
+305
| +16% | +$309K | 0.47% | 81 |
|
2020
Q1 | $1.61M | Buy |
+1,855
| New | +$1.61M | 0.49% | 76 |
|
2018
Q4 | – | Sell |
-1,353
| Closed | -$2.06M | – | 101 |
|
2018
Q3 | $2.06M | Buy |
1,353
+209
| +18% | +$317K | 0.59% | 77 |
|
2018
Q2 | $1.79M | Buy |
1,144
+84
| +8% | +$131K | 0.64% | 72 |
|
2018
Q1 | $1.22M | Buy |
1,060
+249
| +31% | +$288K | 0.79% | 66 |
|
2017
Q4 | $961K | Buy |
811
+169
| +26% | +$200K | 0.78% | 64 |
|
2017
Q3 | $864K | Buy |
642
+85
| +15% | +$114K | 0.89% | 54 |
|
2017
Q2 | $450K | Buy |
+557
| New | +$450K | 0.56% | 81 |
|